Interstitial pneumonitis in canine visceral leishmaniasis.

Seroepidemiological study of canine visceral leishmaniasis in Meshkin shahr, Northwest of Iran

Field Trial of Autoclaved Leishmania Vaccines for Control of Canine Visceral Leishmaniasis in Meshkin-Shahr, Iran

Seroprevalence of canine visceral leishmaniasis in asymptomatic dogs in Iran

Clinically infected dogs have been identified as the main reservoir hosts of visceral leishmaniasis (VL)caused by Leishmania infantum. Recently asymptomatic infected dogs were regarded to be as important asclinically ill dogs. This study was aimed to determine the seroprevalence of L. infantum infection amongasymptomatic dogs in the southwest and central parts of Iran and to investigate possibl...

A Leishmania infantum FML-ELISA for the Detection of Symptomatic and Asymptomatic Canine Visceral Leishmaniasis in an Endemic Area of Iran

Background: Visceral leishmaniasis (VL) is caused by Leishmania infantum in Mediterranean basin and is an endemic disease in some parts of Iran. Canines are the main reservoirs of VL in most of the endemic areas. Different serological methods have been introduced for diagnosis of canine visceral leishmaniasis (CVL). Objective: In this survey a Fucose-Mannose Ligand (FML) ELISA, using native L. ...

Evaluation of a Novel Herbal Immunomodulator Drug (IMOD) in Treatment of Experimental Canine Visceral leishmaniasis

Toxicity and drug resistance against pentavalent antimonials, medications of choice in treatment of leishmaniasis for more than 5 decades, have become important subjects globally. This study was a randomized, open labeled trial that was designed to determine efficacy and safety of IMOD as a novel herbal immunomodulator drug for treatment of canine visceral leishmaniasis (CVL).Twenty healthy mon...